Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Dosing begins in phase II trial of onapristone and anastrozole in endometrial cancer

May 13, 2021

New Angex Pharmaceutical anticancer compounds show preclinical potential

May 13, 2021

ShanghaiTech University, Fudan University patent new PROTACs

May 13, 2021

Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors

May 13, 2021

Galectin-3 mediates the crosstalk between the WNT and STAT3 signaling pathways in gastric cancer

May 13, 2021

Phase IIb trial investigates ABTL-0812 with FOLFIRINOX in pancreatic cancer

May 12, 2021

Dose expansion begins in phase I/II study of darovasertib and crizotinib in MUM

May 12, 2021

New FGFR inhibitors presented by Incyte

May 12, 2021

Sentinel Oncology identifies Wee1 and PLK1 inhibitors

May 12, 2021

Foghorn Therapeutics announces FDA clearance of its IND applications

May 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...